Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Carcinoma, Pancreatic Ductal × Floxuridine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Colonic Neoplasms 1 Carcinoma, Pancreatic Ductal 1 Appendiceal Neoplasms 1

Interventions

pembrolizumab 1 Pemetrexed 1 Paclitaxel 1 Oxaliplatin 1 Leucovorin 1 Gemcitabine 1 Fluorouracil 1 Floxuridine 1 Cisplatin 1 Cetuximab 1 Carboplatin 1 Bevacizumab 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03856658 2025-06-17

Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases

Corewell Health West

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡